| Home | About us | Team | Portfolio | Press | Contact | Careers |
NewsApril 18th 2012MerLion Announces Initiation of a Phase III Clinical Programme to Evaluate Finafloxacin for the Treatment of Acute Otitis Media February 13th 2012 HeidelbergCapital sells its Shares in Framas Kunststofftechnik GmbH January 19th 2012 4SC AG: Cancer compound resminostat meets primary endpoint in Phase II trial in advanced liver cancer ahead of schedule |
HeidelbergCapital is an independent Private Equity Funds Group, specialising in Secondary Direct Investments, e.g. the acquisition of shareholdings in companies previously held by private equity/venture capital funds or banks. |
| Deutsch |  |
Imprint | |
 |
|
|
